Impact BioMedical Inc. (IBO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 7K | 7K | 18K | 7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | -100% | -100% | - | -100% |
| Cost of Goods Sold | 285K | 422K | 1K | 11K | 283K | 0 | 281K | 0 | 0 | 0 | 280K | 280K |
| COGS % of Revenue | 4071.43% | 6028.57% | 5.56% | 157.14% | - | - | - | - | - | - | - | - |
| Gross Profit | -278K | -415K | 17K | -4K | -283K | 0 | -281K | 0 | 0 | 0 | -280K | -280K |
| Gross Margin % | -3971.43% | -5928.57% | 94.44% | -57.14% | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 1.77% | - | 106.05% | - | - | - | - | 100% | -100% | -100% | - | -313.41% |
| Operating Expenses | 2.01M | 743K | 12K | 1.15M | 727K | 26.23M | 846K | 626K | 771K | 1.14M | 798K | 728K |
| OpEx % of Revenue | 28728.57% | 10614.29% | 66.67% | 16414.29% | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.97M | 275K | 236K | 676K | 509K | 591K | 719K | 214K | 305K | 274K | 559K | 462K |
| SG&A % of Revenue | 28071.43% | 3928.57% | 1311.11% | 9657.14% | - | - | - | - | - | - | - | - |
| Research & Development | 46K | 110K | 52K | 75K | 103K | -108K | 82K | 121K | 183K | 463K | 239K | 266K |
| R&D % of Revenue | 657.14% | 1571.43% | 288.89% | 1071.43% | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 358K | -276K | 398K | 115K | 1000K | 45K | 291K | 283K | 402K | 0 | 0 |
| Operating Income | -2.29M | -1.16M | 5K | -1.15M | -1.01M | -26.23M | -1.13M | -626K | -771K | -1.14M | -1.08M | -1.01M |
| Operating Margin % | -32700% | -16542.86% | 27.78% | -16471.43% | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -126.63% | 95.59% | 100.44% | - | - | - | - | 37.9% | -1232.41% | -685.78% | -557.97% | -2202.63% |
| EBITDA | -2M | -872K | 293K | -865K | -727K | -25.95M | -846K | -347K | -491K | -859K | -798K | -728K |
| EBITDA Margin % | -28628.57% | -12457.14% | 1627.78% | -12357.14% | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -175.65% | 96.64% | 134.63% | - | - | - | - | 52.34% | -449.72% | -1037.39% | -718.42% | -2157.19% |
| D&A (Non-Cash Add-back) | 285K | 286K | 288K | 288K | 283K | 279K | 281K | 279K | 280K | 280K | 280K | 280K |
| EBIT | -2.29M | 2.65M | -1.21M | -14.09M | -1.01M | -26.83M | 4.55M | -623K | -768K | -1.14M | -1.07M | -1M |
| Net Interest Income | 5K | 3K | -259K | -257K | -268K | -267K | -302K | -258K | -227K | -122K | -134 | -149 |
| Interest Income | 5K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 0 | 0 |
| Interest Expense | 0 | 0 | 262K | 260K | 271K | 270K | 305K | 261K | 230K | 125K | 134 | 149 |
| Other Income/Expense | 5K | 3.81M | -1.48M | -13.2M | -268K | -869K | 5.37M | -258K | -227K | -122K | -99K | -113K |
| Pretax Income | -2.28M | 2.65M | -1.48M | -14.35M | -1.28M | -27.1M | 4.24M | -884K | -998K | -1.26M | -1.18M | -1.12M |
| Pretax Margin % | -32628.57% | 37928.57% | -8194.44% | -205028.57% | - | - | - | - | - | - | - | - |
| Income Tax | 0 | -2.58M | -5K | 0 | 0 | 33K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -97.18% | 0.34% | 0% | 0% | -0.12% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.29M | 5.25M | -1.47M | -14.35M | -1.27M | -27.11M | 4.25M | -889K | -962K | -1.24M | -1.16M | -1.1M |
| Net Margin % | -32671.43% | 74928.57% | -8166.67% | -204942.86% | - | - | - | - | - | - | - | - |
| Net Income Growth % | -80.51% | 119.35% | -134.61% | - | - | - | - | 19.33% | -97.7% | -55.77% | -38.01% | 83.18% |
| Net Income (Continuing) | -2.28M | 5.24M | -1.47M | -14.35M | -1.28M | -27.13M | 4.24M | -884K | -998K | -1.26M | -1.18M | -1.12M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3.25M | 2.95M | 2.96M | 2.96M | 2.97M | 2.98M | 3M | 3.01M | 3M | 3.04M | 4.16K | 4.08K |
| EPS (Diluted) | -0.02 | 0.05 | -0.12 | -1.18 | -0.10 | -2.36 | 0.06 | -0.08 | -0.08 | -0.11 | -0.03 | -0.03 |
| EPS Growth % | 78.8% | 102.12% | -300% | - | - | - | - | -191.7% | - | - | - | 23.85% |
| EPS (Basic) | -0.02 | 0.05 | -0.12 | -1.18 | -0.10 | -2.36 | 0.37 | -0.08 | -0.08 | -0.11 | -0.02 | -0.02 |
| Diluted Shares Outstanding | 107.79M | 31.55M | 12.19M | 12.19M | 12.06M | 11.51M | 72M | 11.5M | 11.5M | 29.5M | 70.5K | 70.5K |
| Basic Shares Outstanding | 107.79M | 31.55M | 12.19M | 12.19M | 12.06M | 11.51M | 72M | 11.5M | 11.5M | 26.07M | 58.1K | 55.1K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |